title: From perpetual haemosiderinuria to possible iron overload: iron redistribution in paroxysmal nocturnal haemoglobinuria patients on eculizumab by magnetic resonance imaging.
authors.forename: Antonio M
authors.initials: AM
authors.lastname: Risitano
authors.forename: Massimo
authors.initials: M
authors.lastname: Imbriaco
authors.forename: Ludovica
authors.initials: L
authors.lastname: Marando
authors.forename: Elisa
authors.initials: E
authors.lastname: Seneca
authors.forename: Ernesto
authors.initials: E
authors.lastname: Soscia
authors.forename: Luca
authors.initials: L
authors.lastname: Malcovati
authors.forename: Anna P
authors.initials: AP
authors.lastname: Iori
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Pane
authors.forename: Rosario
authors.initials: R
authors.lastname: Notaro
authors.forename: Margherita
authors.initials: M
authors.lastname: Matarazzo
mesh_terms: D000293:Adolescent; D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D006457:Hemoglobinuria, Paroxysmal / Q000097:blood* / Q000188:drug therapy / Q000276:immunology; D006485:Hemosiderin / Q000652:urine*; D006801:Humans; D019190:Iron Overload / Q000097:blood*; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D006485:Hemosiderin; C481642:eculizumab